JR is an employee of Columbia University. He receives grants from Vertex and has received grants from Travere and Mineralys as well as participated on speaker bureaus for Amgen and Glaxo Smith Kline. He is also an advisor or consultant to ANI Pharmaceuticals, Inc, Aurinia Pharmaceuticals Inc., Angion Biomedica Corp, Equillium, GlaxoSmithKline, Mallinckrodt, Beigene, Novartis, Vera Therapeutics, Sanofi, and Travere. At the time of this manuscript submission, JL was an employee of Sanofi and held stocks and/or stock options in the company. At the time of manuscript acceptance, JL is an employee of Travere Therapeutics and holds stocks and/or stock options in the company.